Tolerance of weekly metronomic paclitaxel and carboplatin as neoadjuvant chemotherapy in advanced ovarian cancer patients who are unlikely to tolerate 3 weekly paclitaxel and carboplatin

OBJECTIVE: There are little data regarding safety and effectiveness of neoadjuvant chemotherapy (NACT) in patients who are considered unfit for receiving 3 weekly paclitaxel and carboplatin. The aim of this study was to examine the toxicity and response rates of weekly paclitaxel and carboplatin as...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:South Asian J Cancer
Main Authors: Dessai, S. B., Chakraborty, S., Babu, T. V. S., Nayanar, S., Bhattacharjee, A., Jones, J., Balasubramanian, S., Patil, Vijay M.
Format: Artigo
Sprog:Inglês
Udgivet: Medknow Publications & Media Pvt Ltd 2016
Fag:
METRONOMIC THERAPY IN OVARIAN CANCER: Original Article
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4873699/
https://ncbi.nlm.nih.gov/pubmed/27275450
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/2278-330X.181629
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker